Yearly zoledronic acid in postmenopausal osteoporosis

N Engl J Med. 2007 Aug 16;357(7):711-2; author reply 714-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Atrial Fibrillation / chemically induced*
  • Bone Density Conservation Agents / administration & dosage
  • Bone Density Conservation Agents / adverse effects*
  • Calcium / blood*
  • Diphosphonates / administration & dosage
  • Diphosphonates / adverse effects*
  • Female
  • Fractures, Bone / prevention & control
  • Humans
  • Hypocalcemia / chemically induced
  • Imidazoles / administration & dosage
  • Imidazoles / adverse effects*
  • Osteoporosis, Postmenopausal / drug therapy*
  • Parathyroid Hormone / blood
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Parathyroid Hormone
  • Zoledronic Acid
  • Calcium